CROISSY-BEAUBOURG, France--(BUSINESS WIRE)--Regulatory News: THERADIAG (Paris:ALTER) (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today ...
Two world leaders in the diagnostic market are celebrating a partnership which has resulted in the design, manufacture and sale of 1000 Alegria® Series diagnostic instruments. SCHWALBACH, ...
LISSES, France, June 30, 2021 /PRNewswire/ -- Sebia, a leading provider of clinical protein electrophoresis equipment and reagents for diabetes and oncology detection, today announced the acquisition ...
"The combination of Gary's diagnostic and global experience is the ideal match for Orgentec. We're thrilled to gain the benefit of his years of industry expertise and insight as we build and enhance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results